ITEN Announces Major Breakthrough in Solid-State Li-ion Battery with 200C Discharge C-Rate, Setting a New Industry Standard
9.4.2025 16:52:00 CEST | Business Wire | Press Release
ITEN, a leading innovator and industrial player in the development and production of Surface-Mount Device (SMD) Solid-State Batteries (SBBs) for electronic markets, today unveiled a major advancement in energy storage. ITEN’s latest SSB achieves an unprecedented 200C discharge rate (200 times the battery’s capacity per hour) —100 times higher than conventional Li-ion batteries—setting a new benchmark for miniaturized energy storage. This technology is now being manufactured at scale to build the Powency™ product family, with the company’s high-volume production capabilities ready to meet growing demand for IoT and other connected devices across various industries.
“Our breakthrough solid-state battery technology, driven by ITEN's advanced expertise in nanomaterials, is redefining energy management in electronic devices,” said Vincent Cobée, CEO of ITEN. “With industry-leading power density and full manufacturing readiness, we are solving some of the IoT sector’s most pressing challenges. Our technology is also driving innovation in wearables, healthcare devices, and more, setting a new standard for power efficiency and reliability.”
With over 100 customers across various industries already sampling ITEN batteries and designing connected devices with ITEN’s technology, the Powency™ products are now qualified for full-scale production in the second half of 2025. ITEN’s Dardilly pilot line has the capacity to produce more than 30 million batteries per year, with ongoing plans to launch a high-capacity manufacturing facility by 2028 to meet increasing market demand.
Leveraging Nanomaterials for High-Performance Solutions
This technological advancement is based on ITEN's unique expertise in nanomaterials to engineer full-ceramic electrodes featuring a patented mesoporous structure that significantly enhances their specific surface area. This scalable technology delivers an unmatched combination of power density, recharge speed, safety and reliability. ITEN is currently transforming energy solutions for industries by providing very small, efficient, and long-lasting power sources. This innovation enables new possibilities for a wide range of end markets, reducing dependence on traditional energy storage technologies and offering more sustainable and reliable alternatives.
Unmatched Performance for High-Power IoT Applications and Beyond
ITEN’s Powency™ product family of solid-state batteries is designed for high power density, ideal for delivering rapid energy bursts in wireless sensor applications. The 200C discharge rate is demonstrated by the Powency™ 150 microampere-hours (μAh) model with an 18 mm² footprint, translating into peak current capabilities of 30 milliamps (mA) for 50-millisecond pulse lengths.
All Powency™ batteries will leverage this high-power density attribute to provide the electronics market with area-optimized batteries delivering bursts of current capable of supporting cellular Low Power Wide Area Network (LPWAN) communications.
Conventional Li-ion batteries typically support discharge rates of 2C to 5C, limiting their ability to handle high-power applications. ITEN’s proprietary solid-state battery technology overcomes this constraint, making it an ideal energy buffer when paired with energy harvesters. With their unique power density attribute, these batteries enable instant power delivery, making them particularly suitable for asset tracking, smart homes and buildings, smart agriculture, metering, remote controls, and wireless sensors.
This innovation also enables hybrid architectures where primary batteries are paired with a Powency™ device to improve the cost, lifespan, and sustainability of IoT and other connected devices. Beyond IoT, ITEN is also developing the next generation of SMD solid-state batteries for wearables, consumer and healthcare applications, designed to offer high capacity and energy density for demanding use cases.
Thanks to its solid-state technology, ITEN’s Powency™ batteries retain at least 50% of their capacity at -20°C, whereas conventional Li-ion batteries typically lose 80-90% of their capacity. Additionally, the Powency™ batteries boast a longer cycle life, enduring up to 250 cycles at 100% depth of discharge at 70°C, and recharge quickly - reaching 80% capacity typically in 6 minutes.
ITEN’s full control over the manufacturing process allows the company to create customized battery designs tailored to specific applications.
Enhanced Safety & Higher Sustainability
ITEN’s solid-state battery technology provides enhanced intrinsic safety, eliminating risks of fire, thermal runaway, or ignition. In addition to superior performance, ITEN’s SSBs offer a more sustainable alternative to traditional coin-cell batteries. Their long-lasting, rechargeable design helps reduce battery waste, while the ITEN production process excludes the use of cobalt and heavy solvents. ITEN’s batteries are free of hazardous materials and comply with RoHS (Restriction of Hazardous Substances) and REACH (Registration, Evaluation, Authorization, and Restriction of Chemicals), two key European Union environmental regulations focused on chemical safety and environmental protection. The environmentally responsible manufacturing process also operates at low temperatures, minimizing its ecological footprint.
About ITEN: ITEN is a global leader in solid-state batteries, pioneering high-power, miniaturized energy storage solutions. With over 200 patents and deep expertise in solid-state technology, ITEN is one of the very few companies worldwide with full industrial production capabilities. The company serves industries requiring compact, high-performance energy storage, including IoT, smart sensors, and wearables. Based in Dardilly, France, ITEN is a two-time winner of the Global Innovation Competition and a French Tech 120 laureate, as well as a recipient of the CES 2024 Best of Innovation Award. By the end of 2022, ITEN had secured €80 million in funding.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250409903719/en/
Contacts
Media Contact :
Camille Dufour
International PR Consulting
camille.prconsulting@gmail.com
Mobile: +33 (0) 6 79 49 51 43
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release
inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom